Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Exec shake-up at Janssen

Posted 28 April 2021 PM

Janssen is shaking up its executive team with staff movements in the key areas of immunology and corporate and government affairs. 

After 16 years with Janssen, Jonathan Mullings has left his position as business unit director, immunology to join Italian biopharma Menarini as the head of ANZ. His role at Janssen was filled internally by Meaghan Clarke who moved across from Neuroscience and Infectious Diseases last month.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended